# Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma

> **NCT02437812** · PHASE2 · UNKNOWN · sponsor: **Gynecologic Oncology Associates** · enrollment: 30 (estimated)

## Conditions studied

- Epithelial Ovarian Carcinoma

## Interventions

- **DRUG:** Metformin
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02437812
- **Lead sponsor:** Gynecologic Oncology Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2017-10
- **Final completion:** 2021-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02437812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02437812, "Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02437812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*